We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
-1.67%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$80.5B
AUM Growth
-$3.46B
(-4.1%)
Cap. Flow
-$1.21B
Cap. Flow
% of AUM
-1.5%
Top 10 Holdings %
Top 10 Hldgs %
13.64%
Holding
817
New
51
Increased
266
Reduced
358
Closed
117
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$499M |
| 2 |
Fidelity National Information Services
FIS
|
+$462M |
| 3 |
Honeywell
HON
|
+$367M |
| 4 |
Lennar Class A
LEN
|
+$321M |
| 5 |
Extra Space Storage
EXR
|
+$263M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sanofi
SNY
|
+$486M |
| 2 |
Global Payments
GPN
|
+$421M |
| 3 |
Eaton
ETN
|
+$415M |
| 4 |
Dell
DELL
|
+$391M |
| 5 |
Howmet Aerospace
HWM
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.82% |
| 2 | Technology | 16.67% |
| 3 | Industrials | 16.22% |
| 4 | Healthcare | 11.1% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
IDEAYA Biosciences
IDYA
$3.92B
| – | – |
-13,391
| Closed | -$588K |
|
752
i3 Verticals
IIIV
$294M
| – | – |
-35,525
| Closed | -$813K |
|
753
Ingles Markets
IMKTA
$1.56B
| – | – |
-11,355
| Closed | -$871K |
|
754
InMode
INMD
$854M
| – | – |
-664,672
| Closed | -$13.7M |
|
755
Independence Realty Trust
IRT
$3.88B
| – | – |
-55,310
| Closed | -$892K |
|
756
Kite Realty
KRG
$5.25B
| – | – |
-34,670
| Closed | -$752K |
|
|
LADR
757
Ladder Capital
LADR
$1.24B
| – | – |
-70,707
| Closed | -$787K |
|
758
Liberty Energy
LBRT
$3.08B
| – | – |
-62,683
| Closed | -$832K |
|
759
Liquidia Corp
LQDA
$6.1B
| – | – |
-51,642
| Closed | -$762K |
|
760
LegalZoom.com
LZ
$1.05B
| – | – |
-3,154,584
| Closed | -$41.7M |
|
761
M/I Homes
MHO
$3.82B
| – | – |
-8,879
| Closed | -$1.21M |
|
762
Mueller Industries
MLI
$13.9B
| – | – |
-49,124
| Closed | -$1.32M |
|
763
Manitowoc
MTW
$688M
| – | – |
-15,422
| Closed | -$218K |
|
764
Minerals Technologies
MTX
$2.24B
| – | – |
-14,057
| Closed | -$1.06M |
|
765
Northern Oil and Gas
NOG
$2.72B
| – | – |
-22,307
| Closed | -$885K |
|
766
O-I Glass
OI
$1.14B
| – | – |
-42,974
| Closed | -$713K |
|
767
ONE Gas
OGS
$5B
| – | – |
-10,969
| Closed | -$708K |
|
768
Old Second Bancorp
OSBC
$1.28B
| – | – |
-55,735
| Closed | -$771K |
|
769
Oxford Industries
OXM
$576M
| – | – |
-8,812
| Closed | -$990K |
|
770
Patrick Industries
PATK
$2.66B
| – | – |
-20,657
| Closed | -$1.16M |
|
771
PBF Energy
PBF
$8.46B
| – | – |
-24,200
| Closed | -$1.39M |
|
772
Peoples Bancorp
PEBO
$1.42B
| – | – |
-23,969
| Closed | -$710K |
|
773
Pfizer
PFE
$159B
| – | – |
-3,156,897
| Closed | -$87.5M |
|
774
ePlus
PLUS
$2.28B
| – | – |
-8,260
| Closed | -$649K |
|
|
P
775
Everpure Inc
P
$31.1B
| – | – |
-12,374
| Closed | -$643K |
|
Similar funds
Boston Partners's Q2 2024 Portfolio in Review
As of Q2 2024, Boston Partners held 817 positions worth $80.5B, down 4.1% from $84B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Boston Partners's Q2 2024 filing shows 51 new, 266 increased, 358 reduced and 117 closed positions. Its largest new stake was Honeywell: 1,930,615 shares worth $389M. The largest sale was Sanofi, an estimated $486M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.
- Boston Partners's largest Q2 2024 buy was Honeywell: 1,930,615 shares worth $389M.
- Boston Partners added most to AbbVie in Q2 2024, an estimated $499M increase.
- Boston Partners's biggest Q2 2024 reduction was Sanofi, cutting an estimated $486M.
- Boston Partners fully exited Globe Life in Q2 2024, selling an estimated $243M.
- Boston Partners's ten largest holdings make up 14% of its $80.5B portfolio in Q2 2024.
- Boston Partners opened 51 new positions and closed 117 in Q2 2024.
- Boston Partners's portfolio value fell 4.1% quarter-over-quarter to $80.5B.
Based on Boston Partners's 13F filing for Q2 2024, filed 14 Aug 2024.